Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man
about
Pharmacology of anabolic steroidsEffects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.Testosterone in ageing men.Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive.Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.Dietary fat modulates the testosterone pharmacokinetics of a new self-emulsifying formulation of oral testosterone undecanoate in hypogonadal menFormulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems.Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride.The role of lymphatic transport in enhancing oral protein and peptide drug delivery.The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps.Pharmacological developments in male contraception.Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.Emerging drugs for hypogonadism.The latest options and future agents for treating male hypogonadism.Testosterone depot injection in male hypogonadism: a critical appraisal.Lipid-based drug carriers for prodrugs to enhance drug delivery.Intestinal lymphatic vasculature: structure, mechanisms and functions.Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency.Which testosterone replacement therapy?Important effect of food on the bioavailability of oral testosterone undecanoate.Oral testosterone-triglyceride conjugate in rabbits: single-dose pharmacokinetics and comparison with oral testosterone undecanoate.Pharmacokinetic study in women of three different doses of a new formulation of oral testosterone undecanoate, Andriol Testocaps.Effects of combined estrogen/testosterone therapy on bone and body composition in oophorectomized women.Percutaneous administration of testosterone gel in postmenopausal women--a pharmacological study.Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose.Modern prodrug design for targeted oral drug delivery.Prolactin secretion in the human male is increased by endogenous oestrogens and decreased by exogenous/endogenous androgensThe History of Testosterone and The Testes: From Antiquity to Modern TimesAndrogens and cardiovascular disease in men and womenEffects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study
P2860
Q24650695-114041AE-197F-48A7-B086-207DAE2D5DC2Q30962192-4EF31FC4-1ECC-453C-9419-E55BD4523D7EQ32066338-698CA44F-BEFD-41B0-A93E-99858A8D20E2Q33800970-4553A2AD-84C3-4BEA-8DF1-97C32817CB42Q34207544-9208DAA2-F622-4830-83D3-EC4A24DD23DDQ34219125-0B4DEEAA-A87B-4DBC-B9E0-80B959D0E703Q34285667-8DE0DFA7-D665-4972-8BAE-8C60D9DA1B71Q34722629-07E4D243-E1E3-4E13-8E8D-C385B2CC67A3Q35010729-85D88E98-C377-4DF5-B9CC-0B7FE8DA0B93Q35768803-2E4432A8-1255-46B0-BF24-603BC3A0D33EQ36179775-5CB1ED62-EEEE-45B9-B7BA-747F63141750Q36222083-0CEAB6B1-A605-4B39-9AE0-E0262AA5F7C6Q36634275-D49396CE-1C96-4484-969C-BF848E0D770EQ37000744-AC8FB080-968F-471C-ACE1-64609130FADFQ37069021-85EEC95C-2B97-4CDC-96FE-1BB3054B071CQ38255590-7C8AE59F-4AC5-4AF4-816C-87D6ADA05E76Q39401415-FA7E9569-7EEC-40AC-9274-B7E4D3436807Q39656712-E77EC663-C9F4-4F79-AB78-5E9515F05DDAQ42249957-D06D8775-24D3-4CA5-90BF-AC92B36B5D8AQ44356205-F359C49D-E6CA-433F-8176-995F30953E56Q44572836-299ECF81-595B-4ADA-A50A-7A7B6A03D9FEQ44640103-4CD2199D-E6E7-40A0-A8B1-16B4B7C30C1DQ46600435-65D48CDB-3F9F-40E8-935A-DEB9BACCE201Q46600466-817D4951-A532-4D35-92F5-B36BBE6A6D8AQ49032677-F8F80CA3-37B7-42DC-9520-9AB6D8286FD4Q51042522-613D275B-37AF-41EC-BC28-9C34535C0255Q56672745-0C97B1C7-53BE-443E-AA94-3FF1F3D57058Q57480851-01031504-13C2-46B5-ACF9-5F1E33B6FDBAQ58248183-497F0D79-BBD2-4EFE-90EA-746D34B5437AQ58255187-E8446C88-F3D3-4C3E-94E6-DE4BD1B4C6B4
P2860
Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man
description
1976 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1976
@ast
scientific article (publication date: 15 September 1976)
@en
vedecký článok (publikovaný 1976/09/15)
@sk
vědecký článek publikovaný v roce 1976
@cs
wetenschappelijk artikel (gepubliceerd op 1976/09/15)
@nl
наукова стаття, опублікована у вересні 1976
@uk
научни чланак (објављен 1976/09/15)
@sr
مقالة علمية (نشرت في 15-9-1976)
@ar
name
Lymphatic absorption and metab ...... estosterone undecanoate in man
@ast
Lymphatic absorption and metab ...... estosterone undecanoate in man
@en
Lymphatic absorption and metab ...... estosterone undecanoate in man
@nl
type
label
Lymphatic absorption and metab ...... estosterone undecanoate in man
@ast
Lymphatic absorption and metab ...... estosterone undecanoate in man
@en
Lymphatic absorption and metab ...... estosterone undecanoate in man
@nl
prefLabel
Lymphatic absorption and metab ...... estosterone undecanoate in man
@ast
Lymphatic absorption and metab ...... estosterone undecanoate in man
@en
Lymphatic absorption and metab ...... estosterone undecanoate in man
@nl
P2093
P356
P1476
Lymphatic absorption and metab ...... estosterone undecanoate in man
@en
P2093
P356
10.1007/BF01483589
P407
P577
1976-09-15T00:00:00Z